These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 684591)

  • 1. Preserved saphenous vein allografts for vascular access.
    Piccone VA; Sika J; Ahmed N; LeVeen HH; DiScala V
    Surg Gynecol Obstet; 1978 Sep; 147(3):385-90. PubMed ID: 684591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of preserved saphenous vein graft for the creation of access ports in hemodialyzed patients: report of 309 cases].
    Schneider M; Barrou B; Cluzel P; Hamani A; Bitker MO; Richard F
    Prog Urol; 2003 Sep; 13(4):585-91. PubMed ID: 14650287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brachial artery to brachial vein preserved vein allograft fistulas for hemodialysis.
    Ahmed N; Di Scala V; Nielsen E; Le Veen HH; Piccone VA
    J Cardiovasc Surg (Torino); 1976; 17(6):483-8. PubMed ID: 993249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of arteriovenous autograft and allograft fistulas for chronic hemodialysis.
    Adar R; Siegal A; Bogokowsky H; Mozes M
    Surg Gynecol Obstet; 1973 Jun; 136(6):941-4. PubMed ID: 4703474
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term results of arteriovenous fistulas using transposed autologous basilic vein.
    Murphy GJ; White SA; Knight AJ; Doughman T; Nicholson ML
    Br J Surg; 2000 Jun; 87(6):819-23. PubMed ID: 10928809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vascular access lines: use of biologic grafts].
    Bitker MO; Rottembourg J; Chatelain C
    Ann Urol (Paris); 1985; 19(4):225-7. PubMed ID: 4026215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saphenous vein forearm grafts and gortex thigh grafts as alternative forms of vascular access.
    Bhandari S; Wilkinson A; Sellars L
    Clin Nephrol; 1995 Nov; 44(5):325-8. PubMed ID: 8605714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional contrast-enhanced magnetic resonance angiography (3-D CE-MRA) in the evaluation of hemodialysis access complications, and the condition of central veins in patients who are candidates for hemodialysis access.
    Paksoy Y; Gormus N; Tercan MA
    J Nephrol; 2004; 17(1):57-65. PubMed ID: 15151260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserved allografts of dilated saphenous vein for vascular access in hemodialysis: an initial experience.
    Piccone VA; Lee H; Ramos S; Ahmed N; DiScala V; Hammanci M; Piccone VA; Nielsen E; LeVeen HH; Berger E
    Ann Surg; 1975 Dec; 182(6):727-32. PubMed ID: 1190877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients.
    Fuster V; Charlton P; Boyd A
    Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preserved saphenous grafts in hemodialysis. 20 years' experience].
    Bonnaud P; Lebkiri B; Boudier L; Man NK
    Nephrologie; 1994; 15(2):177-80. PubMed ID: 8047211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of autologous and allogeneic venous grafts for arteriovenous fistulas in chronic haemodialysis.
    Kestlerová M; Kocandrle V; Vrubel J
    Czech Med; 1978; 1(3):169-79. PubMed ID: 100298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic haemodialysis with PTFE arterio-venous grafts.
    Chia KH; Ong HS; Teoh MK; Lim TT; Tan SG
    Singapore Med J; 1999 Nov; 40(11):685-90. PubMed ID: 10709405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis-related steal syndrome: predictive factors and response to treatment with the distal revascularization-interval ligation procedure.
    Yu SH; Cook PR; Canty TG; McGinn RF; Taft PM; Hye RJ
    Ann Vasc Surg; 2008 Mar; 22(2):210-4. PubMed ID: 18346574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Graft or CVC? A prosthetic graft is the better choice].
    Cifarelli M
    G Ital Nefrol; 2009; 26(2):148-53. PubMed ID: 19382069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolonged preservation of venous allografts for vascular access in hemodialysis].
    Manenti A; Baraldi A; Di Felice A; Manca V; Zambruno G; Roncaglia R; Leonelli M
    Acta Urol Belg; 1990; 58(3):47-52. PubMed ID: 2082752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethylsulfoxide-treated, cryopreserved venous allografts in the arterial and venous systems.
    Sitzmann JV; Imbembo AL; Ricotta JJ; McManama GP; Hutchins GM
    Surgery; 1984 Feb; 95(2):154-9. PubMed ID: 6695333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular access for hemodialysis.
    Haimov M
    Surg Gynecol Obstet; 1975 Oct; 141(4):619-25. PubMed ID: 1101423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frozen saphenous vein allografts for constructing vascular access for hemodialysis.
    Halevy A; Weissgarten J; Modai D; Averbukh Z; Orda R
    Isr J Med Sci; 1988 Jan; 24(1):13-4. PubMed ID: 3346143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.